The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 21, 2020
Filed:
May. 21, 2019
Applicant:
Gw Pharma Limited, Cambridge, GB;
Inventor:
Brian Anthony Whittle, Hornsea, GB;
Assignee:
GW Pharma Limited, Cambridge, GB;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/352 (2006.01); A61K 31/05 (2006.01); A61K 36/185 (2006.01); B65D 65/38 (2006.01); B65B 31/00 (2006.01); A61K 9/00 (2006.01); A61K 36/534 (2006.01); A61P 25/28 (2006.01);
U.S. Cl.
CPC ...
B65D 65/38 (2013.01); A61K 9/006 (2013.01); A61K 31/05 (2013.01); A61K 31/352 (2013.01); A61K 36/185 (2013.01); A61K 36/534 (2013.01); A61P 25/28 (2018.01); B65B 31/00 (2013.01);
Abstract
The invention relates to pharmaceutical formulations, and more particularly to formulations containing cannabinoids for administration via a pump action spray. In particular, the invention relates to pharmaceutical formulations, for use in administration of lipophilic medicaments via mucosal surfaces, comprising: at least one lipophilic medicament, a solvent and a co-solvent, wherein the total amount of solvent and co-solvent present in the formulation is greater than 55% wt/wt of the formulation and the formulation is absent of a self emulsifying agent and/or a fluorinated propellant.